Diabetology International

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
HbA1c levels measured by enzymatic assay during off-site health checkups are lower than those measured by on-site HPLC assay
Diabetology International - Tập 11 - Trang 67-71 - 2019
Masafumi Koga, Mari Okuda, Shinya Inada, Shin-ichiro Ueda, Yuko Nakamura, Toshika Okumiya, Midori Ishibashi
HbA1c is widely used as a therapeutic target marker and as a diagnostic marker for diabetes mellitus. This has led to an increasing frequency of HbA1c measurements in current health checkups throughout Japan. In the present study, we compared the HbA1c levels measured by an enzymatic assay (EA-HbA1c) off-site during health checkups with the HbA1c levels measured by on-site ion-exchange high-perfor...... hiện toàn bộ
Correction to: Decline in the estimated glomerular filtration rate (eGFR) following metabolic control and its relationship with baseline eGFR in type 2 diabetes with microalbuminuria or macroalbuminuria
Diabetology International - - 2022
Shoichi Akazawa, Eiji Sadashima, Yoshihisa Sera, Nobuhiko Koga
Low body mass index and old age are useful in predicting the hemoglobin A1c-lowering effect of switching from sitagliptin to dulaglutide in Japanese patients with type 2 diabetes mellitus: a single-center, open-label, single-arm, pilot study
Diabetology International - Tập 9 - Trang 189-195 - 2018
Tomoyuki Iwasaki, Takaomi Kessoku, Takuma Higurashi, Masataka Taguri, Masato Yoneda
The purpose of this study was to clarify the predictive clinical characteristics of therapy switching from sitagliptin to dulaglutide in patients with type 2 diabetes mellitus. This single-center, open-label, investigator-initiated pilot study was conducted in 40 patients with type 2 diabetes mellitus. The patients, who had been treated with 50 mg sitagliptin daily for at least 6 months were switc...... hiện toàn bộ
Effect of dulaglutide and long-acting insulin combination therapy in patients with type 2 diabetes: a retrospective observational study
Diabetology International - Tập 14 - Trang 51-57 - 2022
Kohei Ito, Shinobu Satoh, Yoshinobu Kondo, Haruka Tamura, Masanori Hasebe, Yasuo Terauchi
The study aimed to evaluate the long-term effects of combination therapy comprising dulaglutide and long-acting insulin, on glycemic control in patients with type 2 diabetes. This retrospective observational study included 20 patients with type 2 diabetes who underwent blood glucose management with intensive insulin therapy for a limited period. All patients were switched from intensive insulin th...... hiện toàn bộ
Whole gene deletion mutation of HNF1B and exonic aberration mutations of GCK and HNF1B in patients with MODY in Japan
Diabetology International - Tập 3 - Trang 224-232 - 2012
Miho Takizawa, Naoko Iwasaki, Toshiyuki Yamamoto, Yasuko Uchigata, Yasuhiko Iwamoto
Recent reports indicate that genomic rearrangements are novel causative mutations for maturity onset diabetes of the young (MODY). The aim of this study was to investigate genomic rearrangements in Japanese patients with MODY. Subjects diagnosed with diabetes before the age of 30 years and clinically suspected of having MODY but without identified causative mutations were included in the study (n ...... hiện toàn bộ
Increased nutrition-related risk as an independent predictor of the incidence of hypoglycemia in the hospitalized older individuals with type 2 diabetes: a single-center cohort study
Diabetology International - Tập 12 - Trang 420-429 - 2021
Yoshinobu Kimura, Naoya Kimura, Manabu Akazawa
There are few reports on the association between malnutrition and hypoglycemia. The geriatric nutritional risk index (GNRI) allows risk classification by morbidity and mortality resulting from conditions often associated with malnutrition in older individuals. However, the association between GNRI and hypoglycemia is unclear. This study examined the associations between nutrition-related risk and ...... hiện toàn bộ
Tình trạng hút thuốc có mối liên hệ với suy giảm nhận thức nhẹ được đánh giá bằng bài kiểm tra tình trạng tâm thần mini ở bệnh nhân tiểu đường Nhật Bản Dịch bởi AI
Diabetology International - Tập 7 - Trang 361-367 - 2016
Nao Sonoda, Akiko Morimoto, Satoshi Ugi, Katsutaro Morino, Osamu Sekine, Ken-ichi Nemoto, Hiroshi Maegawa, Naomi Miyamatsu
Chúng tôi đã đánh giá mối liên hệ giữa tình trạng hút thuốc và suy giảm nhận thức nhẹ (MCI) ở bệnh nhân tiểu đường Nhật Bản. Nghiên cứu cắt ngang này bao gồm 323 bệnh nhân tiểu đường, tuổi từ 40 đến 79, được giới thiệu đến một phòng khám ngoại trú về tiểu đường từ tháng 1 đến tháng 7 năm 2013 tại Bệnh viện Đại học Y học Shiga (Otsu, Nhật Bản). Chức năng nhận thức được đánh giá bằng cách sử dụng bà...... hiện toàn bộ
#Tình trạng hút thuốc #suy giảm nhận thức nhẹ #bệnh nhân tiểu đường #Nhật Bản #bài kiểm tra tình trạng tâm thần mini #hồi quy logistic
Remogliflozin: the new low cost SGLT-2 inhibitor for type 2 diabetes mellitus
Diabetology International - Tập 12 - Trang 247-253 - 2020
Shubham Atal, Zeenat Fatima, Sakshi Singh, Sadasivam Balakrishnan, Rajnish Joshi
SGLT-2 inhibitors have recently emerged as an important class of oral drugs for treatment of type 2 diabetes mellitus, especially in patients with cardiovascular or renal impairment, recommended in all recent treatment guidelines. They have additional advantages of weight and blood pressure reduction but also pose problems like genitourinary infections. These drugs generally have a high cost makin...... hiện toàn bộ
Correction to: Glycemic control of people with diabetes over months after the 2018 North Osaka Earthquake
Diabetology International - - 2022
Hirotaka Watanabe, Mitsuyoshi Takahara, Naoto Katakami, Taka‐aki Matsuoka, Iichiro Shimomura
Diabetic ketoacidosis after the second dose of SARS-CoV-2 mRNA vaccination in a patient with pembrolizumab-induced fulminant type 1 diabetes
Diabetology International - Tập 14 - Trang 206-210 - 2022
Kohei Nishino, Kimiko Nakagawa, Eriko Yase, Mariko Terashima, Takashi Murata
We report a case of 77-year-old woman with fulminant type 1 diabetes (T1D) who developed diabetic ketoacidosis (DKA) after the second dose of SARS-CoV-2 vaccine tozinameran. The patient had been diagnosed as having T1D associated with an immune-related adverse event caused by pembrolizumab at the age of 75. After the second dose of tozinameran, she developed DKA and needed intravenous insulin infu...... hiện toàn bộ
Tổng số: 495   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10